Kidney Transplant Recipients Carrying theCYP3A4*22Allelic Variant Have Reduced Tacrolimus Clearance and Often Reach Supratherapeutic Tacrolimus Concentrations-Reference-Cited by-同舟云学术

Kidney Transplant Recipients Carrying theCYP3A4*22Allelic Variant Have Reduced Tacrolimus Clearance and Often Reach Supratherapeutic Tacrolimus Concentrations

Published:2015-01-14 Issue:3 Volume:15 Page:800-805
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Pallet N.¹²³⁴,Jannot A.-S.³⁴⁵,El Bahri M.¹,Etienne I.⁶,Buchler M.⁷,de Ligny B. H.⁸,Choukroun G.⁹,Colosio C.¹⁰,Thierry A.¹¹,Vigneau C.¹²,Moulin B.¹³,Le Meur Y.¹⁴,Heng A.-E.¹⁵,Subra J.-F.¹⁶,Legendre C.¹⁷,Beaune P.¹³⁴,Alberti C.¹⁸,Loriot M. A.¹³⁴,Thervet E.²³⁴

Affiliation:

1. Clinical Chemistry; Hôpital Européen Georges Pompidou; Assistance Publique Hôpitaux de Paris; Paris France

2. Department of Nephrology; Hôpital Européen Georges Pompidou; Assistance Publique Hôpitaux de Paris; Paris France

3. Paris Descartes University; Paris France

4. Sorbonne Paris Cité; INSERM UMRS; 1147 Paris France

5. Department of Medical Informatics and Public Health; Hôpital Européen Georges Pompidou; Assistance Publique Hôpitaux de Paris; Paris France

6. Department of Nephrology; CHU Rouen; Rouen France

7. Department of Nephrology; CHU Tours; Tours France

8. Department of Nephrology; CHU Caen; Caen France

9. Department of Nephrology; CHU Amiens; Amiens France

10. Department of Nephrology; CHU Reims; Reims France

11. Department of Nephrology; CHU Poitiers; Poitiers France

12. Department of Nephrology; CHU Rennes; Rennes France

13. Department of Nephrology; CHU Strasbourg; Strasbourg France

14. Department of Nephrology; CHU Brest; Brest France

15. Department of Nephrology; CHU Clermont-Ferrand; Clermont-Ferrand France

16. Department of Nephrology; CHU Angers; Angers France

17. Department of Nephrology; Necker Hospital; Assistance Publique Hôpitaux de Paris; Paris France

18. Clinical Investigation Center; Assistance Publique-Hôpitaux de Paris; Hôpital Robert Debré; Paris France

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference16 articles.

1. Pharmacogenetics in kidney transplantation: Recent updates and potential clinical applications;Elens;Mol Diagn Ther,2012

2. The pharmacogenetics of calcineurin inhibitor-related nephrotoxicity;Hesselink;Ther Drug Monit,2010

3. Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus;Kamdem;Clin Chem,2005

4. Metabolism of the immunosuppressant tacrolimus in the small intestine: Cytochrome P450, drug interactions, and interindividual variability;Lampen;Drug Metab Dispos,1995

5. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II;Staatz;Clin Pharmacokinet,2010

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influence on tacrolimus dose adjusted concentrations in adult heart transplant recipients;The Pharmacogenomics Journal;2024-02-15

2. Association between CYP3A4 , CYP3A5 and ABCB1 Genotype and Tacrolimus Treatment Outcomes Among Allogeneic HSCT Patients;Pharmacogenomics;2024-01

3. CYP3A5*3 and CYP3A4*22 Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach;Pharmaceutics;2023-11-29

4. Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influences on tacrolimus dose adjusted concentration in adult heart transplant recipients;2023-05-16

5. Pharmacogenetic guided dosing of tacrolimus among fast metabolizers;THE FOURTH SCIENTIFIC CONFERENCE FOR ELECTRICAL ENGINEERING TECHNIQUES RESEARCH (EETR2022);2023